Trademark: 79319025
Word
LEADPHARMA
Status Date
Wednesday, October 12, 2022
Filing Date
Wednesday, June 9, 2021
Abandoned Date
Monday, October 3, 2022
5 pharmaceutical preparations and pharmaceutical products for the treatment and prevention of autoimmune diseases, cancer, metabolic diseases, cardiological diseases, haematological diseases, diabetes, urological diseases, eye diseases, osteoporosis, depression, mental illness, bone diseases, respiratory diseases, asthma, kidney diseases, gastrointestinal diseases
Oct 31, 2023
Final Decision Transaction Processed By Ib
Oct 27, 2023
Limitation From The Ib Examined, No Action Is Needed
Oct 12, 2023
Final Disposition Notice Sent To Ib
Oct 12, 2023
Final Disposition Notice Created, To Be Sent To Ib
Aug 19, 2023
Limitation Of Goods Received From Ib
Apr 12, 2023
Notification Of Possible Opposition - Processed By Ib
Mar 22, 2023
Notification Of Possible Opposition Sent To Ib
Mar 22, 2023
Notification Of Possible Opposition Created, To Be Sent To Ib
Oct 12, 2022
Abandonment Notice Mailed - Failure To Respond
Oct 12, 2022
Abandonment Notice Mailed - Failure To Respond
Oct 12, 2022
Abandonment - Failure To Respond Or Late Response
Apr 25, 2022
Refusal Processed By Ib
Apr 1, 2022
Non-Final Action Mailed - Refusal Sent To Ib
Mar 31, 2022
Refusal Processed By Mpu
Mar 2, 2022
Non-Final Action (Ib Refusal) Prepared For Review
Mar 1, 2022
Non-Final Action Written
Feb 28, 2022
Assigned To Examiner
Nov 12, 2021
Correction From Ib Entered - No Review Required
Oct 29, 2021
Correction Transaction Received From Ib
Sep 7, 2021
Application Filing Receipt Mailed
Sep 3, 2021
New Application Office Supplied Data Entered
Sep 2, 2021
Limitation From Original Application Entered
Sep 2, 2021
Sn Assigned For Sect 66a Appl From Ib
Trademark Alertz updated from USPTO on 2030-01-24
